HER2 therapy

SOUTH SAN FRANCISCO, Calif., May 7, 2026 ALX Oncology announced promising new clinical findings showing that its investigational CD47...

SHANGHAI, China, April 1, 2026 Shanghai Henlius Biotech, Inc. announced that the China National Medical Products Administration (NMPA) has...

NEW YORK, NEW YORK, UNITED STATES — February 17, 2026 OS Therapies has announced a major global regulatory update...